학술논문
P-025: Investigating the effect of irreversible proteasome inhibitor carfilzomib in in vivo models of cardiometabolic syndrome and early stage HFrEFP: prophylactic role of metformin
Document Type
Abstract
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S49-S50
Subject
Language
ISSN
2152-2650